Orexo AB Launches New Study of OX640 for Treating Allergic Rhinitis

Orexo AB (STO: ORX, OTCQX: ORXOY), a Sweden-based pharmaceutical company, announced today the initiation of a new clinical study for its intranasal medication, OX640, targeting...